The 12 hallmarks of aging are the cellular and molecular processes that drive biological aging across every organ, including skin. They were defined by Carlos López-Otín and colleagues in the 2023 update to their landmark Cell paper, which expanded the original 9 hallmarks (2013) to 12 (López-Otín et al., Cell, 2023).
I am a board-certified dermatologist, and I have spent two decades watching these processes play out on patients' faces. The framework matters because almost every anti-aging product on the market targets only one or two of these mechanisms, when in reality your skin is failing at all 12 simultaneously. This guide is the long version of what I tell my patients in the clinic, with the citations attached.
TL;DR for citation: The 12 hallmarks of aging (López-Otín et al., 2023) are genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis. Each one has a specific manifestation in skin and a defined molecular target.
---
What are the 12 hallmarks of aging?
The 12 hallmarks of aging are the consensus cellular and molecular drivers of biological decline, originally defined as 9 by López-Otín et al. in 2013 and expanded to 12 in the 2023 update published in Cell (López-Otín et al., 2023). The framework has been cited over 25,000 times and is the closest thing dermatology has to a periodic table of aging.
The history: from 9 hallmarks to 12
The original 2013 paper grouped aging into three tiers: primary hallmarks (the upstream causes), antagonistic hallmarks (responses gone wrong), and integrative hallmarks (downstream phenotypes). For ten years, this was the working model in geroscience.
In 2023, López-Otín's team added three new hallmarks based on a decade of fresh research. Disabled macroautophagy was elevated from a sub-process of proteostasis to its own hallmark. Chronic inflammation, often called inflammaging, was promoted from a downstream effect to a primary driver. Dysbiosis (microbiome dysregulation) was added in recognition of how profoundly bacterial communities shape host aging.
Why this matters for skincare
Most skincare formulations launched between 2010 and 2020 were built against the 2013 framework, and most of them target only 1-2 hallmarks. Vitamin C serums target genomic instability through antioxidant activity. Retinoids partially target proteostasis and stem cell exhaustion. Peptides nudge intercellular communication. None of them, on their own, address the 2023 additions, particularly inflammaging and microbiome dysbiosis, which we now know are upstream drivers, not downstream symptoms.
Citation capsule: The 12 hallmarks of aging framework, updated by López-Otín, Blasco, Partridge, Serrano, and Kroemer in Cell (2023, vol. 186, pp. 243-278, DOI: 10.1016/j.cell.2022.11.001), expanded the original 2013 taxonomy from 9 to 12 hallmarks by adding disabled macroautophagy, chronic inflammation, and dysbiosis. It is the consensus model for biological aging in 2026.
INTERNAL LINK already embedded: see "the [GMA7 patent" referenced below]
---
What is genomic instability and how does it age skin?
Genomic instability is the accumulation of DNA damage in cell nuclei faster than the cell can repair it. In skin, the dominant source is ultraviolet radiation. UVB causes pyrimidine dimers; UVA generates reactive oxygen species that oxidize DNA bases. Up to 100,000 DNA lesions per cell per day occur in sun-exposed skin (Lindahl, Nature, 1993).
On the face, this hallmark presents as solar lentigines (sun spots), actinic keratoses, mottled pigmentation, and the diffuse leathery texture of chronic photodamage. The skin's repair machinery, particularly nucleotide excision repair, weakens with age (Yamada et al., Photochem Photobiol Sci, 2006).
Citation capsule: Cumulative ultraviolet exposure causes thousands of DNA lesions per cell daily, and DNA repair capacity declines with age. The cosmetic enzyme photolyase, derived from blue-green algae, has been shown to enhance repair of UV-induced cyclobutane pyrimidine dimers when applied topically (Berardesca et al., Photodermatol Photoimmunol Photomed, 2012).
Active ingredients that target this hallmark: photolyase, niacinamide, and broad-spectrum mineral SPF. Sajic Protectif sunscreen was formulated with this hallmark as its primary target. Read the full guide to genomic instability and skin aging (forthcoming spoke post).
---
What is telomere attrition and why do skin cells stop dividing?
Telomeres are the protective DNA caps at the ends of chromosomes. Each cell division shortens them. When telomeres reach a critical length, the cell enters replicative senescence, halting division and often releasing inflammatory signals. Skin fibroblasts and keratinocytes both undergo telomere shortening with age (Buckingham & Klingelhutz, Exp Dermatol, 2011).
Clinically, telomere attrition shows up as thinning of the dermis, slower wound healing, and the loss of skin's recoil. Photodamaged skin shows accelerated telomere shortening compared to sun-protected skin, suggesting that UV exposure is a telomere stressor independent of replication (Kosmadaki & Gilchrest, Micron, 2004).
Citation capsule: Fibroblast telomere length correlates inversely with chronological skin age, and ultraviolet radiation accelerates the process. Buckingham and Klingelhutz reviewed the role of telomere dynamics in keratinocyte senescence in Experimental Dermatology (2011), confirming telomere attrition as a primary driver of dermal thinning.
Read the full guide to telomere attrition in skin (forthcoming).
---
What are epigenetic alterations in aging skin?
Epigenetic alterations are heritable changes in gene expression that do not involve changes in DNA sequence. The two best-studied are DNA methylation patterns and histone modifications. Steve Horvath's "epigenetic clock" demonstrated that DNA methylation at specific CpG sites predicts biological age more accurately than chronological age (Horvath, Genome Biol, 2013).
Skin-specific methylation studies have identified hundreds of CpG sites that drift with age in keratinocytes and fibroblasts (Bormann et al., Aging Cell, 2016). The visible result: dysregulated production of collagen, elastin, and pigmentation enzymes. Patients describe it as "my skin doesn't behave like it used to."
Citation capsule: Horvath's epigenetic clock (Genome Biology, 2013) established DNA methylation as a biomarker of biological age, and skin-specific studies confirm methylation drift in dermal fibroblasts with chronological aging. Bakuchiol has been investigated for retinoid-like epigenetic effects in keratinocytes.
Bakuchiol, the retinol alternative used in Sajic Rejuvenat, modulates retinoic-acid-receptor pathways without the methylation-disrupting irritation of tretinoin. Read the full guide to epigenetic skin aging (forthcoming).
---
What is loss of proteostasis in skin?
Proteostasis is the cell's ability to maintain a healthy proteome: properly folded, properly trafficked, properly degraded proteins. Loss of proteostasis means damaged proteins accumulate. In skin, this primarily manifests as cross-linked collagen and degraded elastin fibers (Naylor et al., Maturitas, 2011).
Aged skin shows a measurable decline in fibroblast collagen synthesis combined with rising matrix metalloproteinase (MMP) activity (Quan et al., J Investig Dermatol Symp Proc, 2009). The visible result is the wrinkle: a region of dermis where damaged proteins outweigh fresh ones. Glycation, in which sugars bind to proteins to form advanced glycation end products (AGEs), is a second proteostasis insult especially relevant in patients with diabetes or high sugar intake.
Citation capsule: Quan and colleagues documented in Journal of Investigative Dermatology (2009) that aged human skin shows a 75% reduction in collagen-stimulating signaling combined with elevated MMP-1 activity. Topical peptides, including palmitoyl tripeptide-1 and copper tripeptide, can stimulate dermal fibroblast collagen synthesis.
Active ingredients that target proteostasis: signal peptides (Matrixyl), copper tripeptide GHK-Cu, and carrier peptides. Found in Sajic Renutriate. Read the full guide to loss of proteostasis in skin (forthcoming).
---
What is disabled macroautophagy? (NEW in 2023)
Macroautophagy is the cell's recycling system: damaged organelles and protein aggregates are engulfed in autophagosomes and degraded in lysosomes. When autophagy fails, cellular debris accumulates and signals dysfunction. The 2023 Cell update promoted disabled macroautophagy from a sub-process of proteostasis to its own hallmark (López-Otín et al., 2023).
In skin, autophagy declines with age in both keratinocytes and melanocytes (Eckhart et al., J Invest Dermatol, 2019). Reduced melanocyte autophagy contributes to age-related pigment dyschromia. Reduced keratinocyte autophagy slows the turnover of damaged proteins, compounding proteostasis loss.
Citation capsule: Eckhart and colleagues reviewed autophagy in skin biology in the Journal of Investigative Dermatology (2019) and concluded that autophagy declines measurably with chronological age in both epidermal and dermal compartments. Spermidine and resveratrol are among the topical agents under investigation as autophagy inducers.
Read the full guide to autophagy and skin aging (forthcoming).
---
What is deregulated nutrient sensing?
Nutrient sensing is the cell's ability to read its energetic environment through pathways including mTOR (sense of abundance), AMPK (sense of scarcity), sirtuins (NAD+ sensors), and IGF-1 signaling. With age, these pathways shift toward chronic mTOR activation and reduced AMPK responsiveness (Johnson et al., Nature, 2013).
In skin, mTOR hyperactivation in keratinocytes drives hyperplasia and contributes to actinic keratoses. Reduced AMPK activity correlates with impaired wound healing (Liu et al., Aging Cell, 2015). Topical rapamycin has shown anti-aging effects in clinical trials by inhibiting mTOR (Chung et al., Geroscience, 2019).
Citation capsule: Chung and colleagues reported in Geroscience (2019) that topical rapamycin reduced age-related markers in human skin in a placebo-controlled trial, validating mTOR as a topical aging target. Niacinamide and resveratrol act on overlapping nutrient-sensing pathways.
Read the full guide to nutrient sensing in skincare (forthcoming).
---
What is mitochondrial dysfunction in skin cells?
Mitochondria produce ATP, the energy currency of the cell. They also produce reactive oxygen species as a byproduct. With age, mitochondrial efficiency declines, ROS production rises, and mitochondrial DNA accumulates damage. The "common deletion" in mtDNA is up to 10-fold higher in photoaged skin compared to sun-protected skin (Birch-Machin & Bowman, Int J Cosmet Sci, 2016).
Visibly, mitochondrial dysfunction shows up as the dull, grey-toned, low-vitality skin patients describe as "tired-looking," along with the cellular fatigue that slows recovery from procedures.
Citation capsule: Birch-Machin and Bowman documented in the International Journal of Cosmetic Science (2016) that the mitochondrial DNA "common deletion" accumulates with chronological age and is dramatically elevated in photoaged skin. Copper tripeptide GHK-Cu has been shown to upregulate mitochondrial gene expression in dermal fibroblasts.
Active ingredients that target mitochondria: copper tripeptide (GHK-Cu), CoQ10, idebenone, and PQQ. Found in Sajic Renutriate Restorative. Read the full guide to mitochondrial dysfunction in skin (forthcoming).
---
What is cellular senescence and the "zombie cell" problem?
Cellular senescence is the state in which a damaged cell stops dividing but refuses to die. Instead, it persists and secretes a cocktail of inflammatory cytokines and proteases known as the senescence-associated secretory phenotype (SASP) (Coppé et al., Annu Rev Pathol, 2010). I cover this hallmark in my TEDx talk because it is the most underappreciated driver of visible aging.
Senescent fibroblasts accumulate in aged dermis and degrade the surrounding extracellular matrix via SASP-secreted MMPs (Ressler et al., Aging Cell, 2006). In my clinic, this is the hallmark patients can feel before they can see: a loss of skin "bounce," a slow but persistent crepiness around the eyes, a slackening that creams alone cannot tighten.
Citation capsule: Coppé and colleagues defined the senescence-associated secretory phenotype in Annual Review of Pathology (2010), establishing that senescent dermal fibroblasts secrete IL-6, IL-8, and MMP-1 at levels sufficient to remodel the local extracellular matrix. Senolytics including fisetin and quercetin are under topical investigation.
Read the full guide to cellular senescence in skin (forthcoming spoke post).
---
What is stem cell exhaustion in skin?
Skin contains several stem cell populations: epidermal stem cells in the basal layer, hair follicle stem cells in the bulge region, and melanocyte stem cells. Stem cell exhaustion means these populations decline in number and function with age (Liu et al., Cell Stem Cell, 2019).
Hair follicle stem cell decline contributes to greying and miniaturization of follicles. Epidermal stem cell decline slows wound healing and barrier renewal (Giangreco et al., Aging Cell, 2008). The visible result: thinner epidermis, slower turnover, longer recovery from procedures.
Citation capsule: Liu and colleagues documented in Cell Stem Cell (2019) that epidermal stem cell function declines measurably in aged human skin, slowing barrier repair and contributing to atrophy. Bakuchiol and topical retinoids have been shown to support epidermal stem cell turnover.
Read the full guide to stem cell exhaustion in skin (forthcoming).
---
What is altered intercellular communication?
Cells do not age in isolation. They speak to each other through cytokines, growth factors, exosomes, and direct contact. With age, this signaling becomes noisy and dysregulated. Aged dermal fibroblasts release pro-inflammatory cytokines that recruit immune cells and disrupt epidermal homeostasis (Salzer et al., Cell, 2018).
The visible manifestation is what dermatologists call "skin terrain instability": the pattern in which aged skin reacts more strongly to environmental stressors, takes longer to calm, and develops more pronounced erythema. Topical growth factors (TGF-β, EGF, bFGF) attempt to restore youthful signaling.
Citation capsule: Salzer and colleagues showed in Cell (2018) that aged dermal fibroblasts shift toward an adipogenic, pro-inflammatory phenotype that disrupts epidermal differentiation. Recombinant growth factors and signal peptides can partially restore youthful communication patterns.
Read the full guide to altered intercellular communication (forthcoming).
---
What is chronic inflammation (inflammaging)? (NEW in 2023)
Inflammaging is the chronic, low-grade, sterile inflammation that accumulates with age across all tissues. It was promoted to a primary hallmark in the 2023 update because the evidence now positions it as upstream cause, not downstream consequence (Franceschi et al., Nat Rev Endocrinol, 2018).
In skin, inflammaging shows up as persistent low-grade redness, reactive flare patterns, increased rosacea-spectrum behavior with age, and the subclinical inflammation visible in confocal microscopy of "normal" aged skin. UV is the primary external accelerator; SASP from senescent cells is the primary internal source.
Citation capsule: Franceschi and colleagues reviewed inflammaging in Nature Reviews Endocrinology (2018), establishing chronic low-grade inflammation as an upstream driver of aging across organs including skin. Hidrox (hydroxytyrosol from olive), niacinamide, and centella asiatica show topical anti-inflammaging activity.
Read the full guide to inflammaging skincare (forthcoming spoke post).
---
What is dysbiosis of the skin microbiome? (NEW in 2023)
Dysbiosis is the disruption of healthy microbial community structure. The skin hosts a complex microbiome dominated by Cutibacterium, Staphylococcus, Corynebacterium, and various commensal fungi. With age, this community shifts: diversity declines, Cutibacterium acnes populations drop, and pro-inflammatory species rise (Howard et al., J Invest Dermatol, 2022).
In my clinic, I have observed that patients in their 60s and 70s show markedly different reactivity patterns to identical formulations than patients in their 30s, and the microbiome literature now offers a mechanism: bacterial communities are part of the skin's barrier function, and they age too.
Citation capsule: Howard and colleagues documented in the Journal of Investigative Dermatology (2022) that aged skin shows reduced microbial diversity and a shift toward pro-inflammatory species, supporting dysbiosis as a primary hallmark. Ceramides, prebiotic oligosaccharides, and pH-balanced cleansers help support microbial homeostasis.
Read the full guide to skin microbiome and aging (forthcoming spoke post).
---
How does GMA7 address multiple hallmarks at once?
GMA7 (Genoplex Microdelivery Activator) is the patented delivery technology I designed to carry multi-active formulations through the stratum corneum to dermal cellular targets. It was the subject of the peer-reviewed clinical study I co-authored in the Journal of Cosmetic Dermatology (Sajic et al., 2021, PMID 33740839).
The single-active problem in cosmeceuticals is well known: even an excellent ingredient can only target one or two hallmarks. A vitamin C serum, no matter how stable, addresses genomic instability and partially addresses proteostasis. It does not touch dysbiosis, autophagy, or stem cell exhaustion. Patients who plateau on single-active routines are usually plateauing because their other 10 hallmarks are unaddressed.
How GMA7 enables multi-hallmark targeting
GMA7's architecture allows simultaneous delivery of antioxidants, peptides, photolyase, copper tripeptide, and bakuchiol in a single formulation. The technology is designed around the molecular size and charge characteristics needed to cross the stratum corneum and reach dermal fibroblasts, the cell type that hosts the largest portion of skin-relevant hallmark biology.
Citation capsule: GMA7 (Genoplex Microdelivery Activator) is a patented delivery technology designed to carry multi-active anti-aging formulations to dermal targets. The technology was clinically evaluated in a peer-reviewed study published in the Journal of Cosmetic Dermatology (Sajic et al., 2021, DOI: 10.1111/jocd.14084).
The flagship product built on this technology is Rejuvenat. It pairs with Renutriate Restorative and Protectif sunscreen for full multi-hallmark coverage.
---
Why do most skincare products only target 1-2 hallmarks?
The cosmeceutical industry was largely built on single-active formulations because regulators, retailers, and marketing teams all prefer a single hero ingredient. A bottle that says "Vitamin C 15%" sells better than one that says "Multi-active formulation targeting 6 cellular pathways." This is a marketing problem, not a science problem.
The single-active ceiling
Even best-in-class single actives have a measurable efficacy ceiling. Topical L-ascorbic acid at 15-20% has been studied in dozens of trials. The effect size on photoaging is real but modest, on the order of 10-15% improvement in clinical wrinkle scores over 12 weeks (Humbert et al., Exp Dermatol, 2003). The same ceiling exists for retinol, niacinamide, and the standard peptides. Each one targets 1-2 hallmarks well, then stops.
What gets ignored
When a routine consists of vitamin C in the morning, retinol at night, and a moisturizer, the patient is targeting genomic instability (vitamin C, partially), proteostasis (retinol, partially), and not much else. Eight to nine hallmarks are receiving zero topical intervention. This is why patients on "complete" routines still see continued aging: the routine is incomplete by hallmark coverage.
The case for multi-hallmark formulation
The clinical case for multi-hallmark targeting is straightforward. Aging is parallel, not serial. The 12 hallmarks are happening simultaneously. A topical regimen that addresses 5-6 hallmarks should outperform one that addresses 1-2, all else equal. Read more on the evidence behind cosmeceutical claims.
---
How do you choose products that address multiple hallmarks?
Choosing for multi-hallmark coverage takes about ten minutes per product if you know what to look for. The principle: read the INCI list, identify each active, and map it to the hallmarks it targets. If the bottle has one active and ten silicones, that bottle targets one hallmark.
A 5-step framework
- Open the INCI (ingredient list). It is required by law on every product and lists ingredients in descending order by concentration.
- Identify the actives. Antioxidants (vitamin C, vitamin E, ferulic acid, hidrox), peptides (Matrixyl, copper tripeptide, palmitoyl peptides), retinoids or alternatives (retinol, retinal, bakuchiol), enzymes (photolyase), and microbiome-supportive ingredients (ceramides, prebiotic oligosaccharides) are the hallmark-targeting categories.
- Map each active to a hallmark. Use the ingredient-to-hallmark crosswalk on this site as a reference.
- Count distinct hallmarks covered. A serum with vitamin C plus copper peptide plus bakuchiol is touching genomic instability, mitochondrial dysfunction, and epigenetic alterations. Three hallmarks is good. Four to five is excellent.
- Avoid duplication. Two antioxidant serums layered together do not target two hallmarks; they target one twice. Layer for hallmark diversity, not concentration overlap.
Red flags on a label
INCI red flags: a long preamble of solvents and silicones with the actives buried at position 15+; "proprietary blend" listed without specifying actives; "anti-aging complex" with no named molecule; concentrations only stated in marketing copy, not on the label or clinical study.
Green flags
Named molecules at meaningful concentrations, peer-reviewed citations on the brand's clinical evidence page, MSDS or stability data available, and dermatologist authorship behind the formulation.
Layering strategy
Morning: antioxidant + sunscreen for genomic instability + photoaging defense. Evening: peptide-rich treatment for proteostasis + intercellular communication, with a retinoid alternative or retinoid for epigenetic and stem cell support. Twice weekly: barrier-supportive ceramide cream for microbiome and proteostasis. This four-touchpoint pattern covers 6-7 hallmarks for most patients.
---
Frequently Asked Questions
What is the difference between the 9 hallmarks and 12 hallmarks of aging?
The original López-Otín et al. 2013 paper identified 9 hallmarks. The 2023 update added three new hallmarks: disabled macroautophagy (promoted from a sub-process of proteostasis), chronic inflammation (inflammaging), and dysbiosis. The 12-hallmark framework is now the consensus model.
Can skincare really reverse cellular aging?
Topical skincare cannot fully reverse cellular aging, but peer-reviewed evidence shows it can partially address several hallmarks. Topical rapamycin reduced aging markers in a placebo-controlled trial (Chung et al., Geroscience, 2019). Photolyase repairs UV-induced DNA damage. The honest answer: meaningful improvement is possible, but not full reversal.
Which hallmark is most important to target first?
For most patients over 35, I prioritize genomic instability (UV protection) and chronic inflammation (inflammaging). UV protection is non-negotiable because it accelerates 7 of the 12 hallmarks simultaneously (Bosch et al., Antioxid Redox Signal, 2015). Anti-inflammatory ingredients then prevent the senescent-cell cascade that drives the rest.
How does inflammaging differ from regular inflammation?
Regular inflammation is acute, useful, and resolves once the trigger is gone. Inflammaging is chronic, sterile, low-grade, and does not resolve (Franceschi et al., Nat Rev Endocrinol, 2018). It is driven by senescent cells, mitochondrial dysfunction, and microbiome shifts. Topical anti-inflammatory ingredients alone cannot resolve it, but they can reduce its skin manifestations.
Is the skin microbiome really part of aging?
Yes. The 2023 Cell paper formally added dysbiosis as a hallmark of aging based on a decade of microbiome research. Aged skin shows reduced microbial diversity and a shift toward pro-inflammatory species (Howard et al., 2022). Microbiome-supportive ingredients, including ceramides and prebiotic oligosaccharides, are now considered legitimate anti-aging actives.
What's the best ingredient for cellular senescence?
Senolytic research is early. The most promising topical candidates in 2026 are fisetin, quercetin, and certain peptides under investigation in clinical trials (Yousefzadeh et al., EBioMedicine, 2018). The strongest evidence-based approach is preventive: aggressive UV protection, anti-inflammatory ingredients, and supporting cellular cleanup pathways through autophagy-friendly habits.
How long does it take to see results from anti-aging skincare?
Visible changes in barrier hydration appear in 2-4 weeks. Pigmentation responses to actives take 8-12 weeks. Wrinkle reduction and dermal remodeling are measurable at 12-24 weeks in well-designed clinical trials, including the GMA7 study (Sajic et al., 2021). Patients who see no change at 6 months are typically using single-active routines that miss multiple hallmarks.
Are these 12 hallmarks scientifically proven?
The 12 hallmarks are the consensus framework used in geroscience and have been cited over 25,000 times (López-Otín et al., 2023). Each hallmark is supported by hundreds to thousands of peer-reviewed studies. The skin-specific applications cited throughout this guide are drawn from the dermatology literature with PMIDs provided. This is mainstream science, not speculation.
---
The bottom line for your skin
The 12 hallmarks of aging give us, for the first time, a coherent map of why skin ages. Most products on the market were designed before this map existed. The next decade of cosmeceutical formulation will be measured by how many hallmarks a product actually addresses, not how loud its marketing is.
If you want to apply this framework practically: start with Protectif sunscreen for genomic instability defense, layer Rejuvenat for multi-hallmark dermal targeting via GMA7, and use Renutriate Restorative for proteostasis and mitochondrial support. The full clinical rationale is on the science page, and you can read my own peer-reviewed work on GMA7 directly on PubMed.
Read next: What is GMA7? The patented delivery technology explained and Who is Dr. Dusan Sajic?.
---
About the Author
Dr. Dusan Sajic, MD, FRCPC, FAAD is a board-certified dermatologist with 22+ years of clinical practice, Past President of CLASS (Canadian Laser and Aesthetic Specialists Society), TEDx speaker, and inventor of the patented GMA7 (Genoplex Microdelivery Activator) delivery technology. He founded Sajic Skin Science in 2007 and continues to lead product development from his clinic in Ontario, Canada. Read his full founder profile.
Last reviewed: May 22, 2026 by Dr. Dusan Sajic, MD, FRCPC, FAAD.
---
References & Further Reading
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The Hallmarks of Aging. Cell. 2013;153(6):1194-1217. doi.org/10.1016/j.cell.2013.05.039
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278. doi.org/10.1016/j.cell.2022.11.001
- Kennedy BK, Berger SL, Brunet A, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159(4):709-713. doi.org/10.1016/j.cell.2014.10.039
- Campisi J, Kapahi P, Lithgow GJ, et al. From discoveries in ageing research to therapeutics for healthy ageing. Nature. 2019;571(7764):183-192. doi.org/10.1038/s41586-019-1365-2
- Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 2005;6(8):611-622. doi.org/10.1038/nrg1656
- Sun N, Youle RJ, Finkel T. The Mitochondrial Basis of Aging. Mol Cell. 2016;61(5):654-666. doi.org/10.1016/j.molcel.2016.01.028
- Hwang ES, Yoon G, Kang HT. A comparative analysis of the cell biology of senescence and aging. Cell Mol Life Sci. 2009;66(15):2503-2524. doi.org/10.1007/s00018-009-0034-2
- Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462-1470. doi.org/10.1001/archderm.138.11.1462
- Pilkington SM, Bulfone-Paus S, Griffiths CEM, Watson REB. Inflammaging and the Skin. J Invest Dermatol. 2021;141(4S):1087-1095. doi.org/10.1016/j.jid.2020.11.006
- Quan T, Fisher GJ. Role of Age-Associated Alterations of the Dermal Extracellular Matrix Microenvironment in Human Skin Aging: A Mini-Review. Gerontology. 2015;61(5):427-434. doi.org/10.1159/000371708
- Krutmann J, Bouloc A, Sore G, Bernard BA, Passeron T. The skin aging exposome. J Dermatol Sci. 2017;85(3):152-161. doi.org/10.1016/j.jdermsci.2016.09.015
- Schosserer M, Grillari J, Breitenbach M. The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy. Front Oncol. 2017;7:278. doi.org/10.3389/fonc.2017.00278
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment decisions.
